A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain
Conditions
Interventions
- DRUG: RN624 (PF-04383119)
- DRUG: RN624 (PF-04383119)
- DRUG: RN624 (PF-04383119)
- DRUG: RN624 (PF-04383119)
- DRUG: RN624 (PF-04383119)
- DRUG: placebo
Sponsor
Pfizer